Diagnostics
CT Coronary Calcium Score Tops CRP as Guide to Therapy
August 19, 2011 9:38 am | by Diagnostic Imaging | News | CommentsCoronary artery calcium (CAC) scores based on cardiac CT scans can stratify the risk of heart disease among those without symptoms, a new study reports.
AHRA 2011: Get 'Er Done: Management Best Practices from the Pros
August 19, 2011 7:39 am | by Diagnostic Imaging | News | CommentsGRAPEVINE, TX -No one's plates are getting any less full these days. So when thrown a new work project, it's best to breathe and strategize, practice management consultants told attendees of the annual AHRA conference this week.
Nuclea Biotechnologies lands $3M funding
August 18, 2011 8:37 pm | by Mass High Tech: The Journal of New England Technology | News | CommentsNuclea Biotechnologies LLC, a cancer diagnostics firm in Pittsfield, has rounded up $3 million in an equity offering backed by 28 investors, the company revealed in federal documents.
Industry Leaders Hinson and Friel Join Wright Therapy Products
August 18, 2011 8:40 am | by Bio-Medicine.Org | News | CommentsPITTSBURGH, Aug. 18, 2011 /- Wright Therapy Products, Inc. announced today that Michael Hinson has been appointed President and Chief Executive Officer of the company. The company, based in Oakdale, PA, manufactures and sells pneumatic compression devices targeted for the treatment...
AHRA 2011: Debt-weary Feds Eyeing Imaging Cuts
August 18, 2011 5:42 am | by Diagnostic Imaging | News | CommentsEveryone from radiologists to technologists must address upcoming health care changes, as the imaging industry reels from - and faces probable new - cuts in federal funding, said Maggie Sayre, executive director of the Association for Quality Imaging in Washington, D.C.
Chembio Diagnostics' CFO Richard J. Larkin Among the Recipients of "2011 CFO of the Year" Award from Long Island Business News
August 18, 2011 5:42 am | by Bio-Medicine.Org | News | CommentsMEDFORD, N.Y., Aug. 18, 2011 /- Richard Larkin, Chief Financial Officer of Chembio Diagnostics, Inc. (OTCQB: CEMI) (OTC.BB: CEMI), which develops, manufactures, markets and licenses point-of-care diagnostic tests, is among the recipients of the "2011 CFO of the Year" award from Long...
AHRA 2011: Malpractice Suits Down, but Potential Liability Lingers
August 17, 2011 6:36 am | by Diagnostic Imaging | News | CommentsGRAPEVINE, TEXAS - Facing a medical malpractice lawsuit can be a daunting, years-long process. But Detroit lawyer David M. Ottenwess had some simple, initial advice for radiology managers: Don't panic.
AHRA 2011: Industry Slow to Colombini MRI Lessons?
August 17, 2011 6:35 am | by Diagnostic Imaging | News | CommentsGRAPEVINE, TEXAS - A decade after a 6-year-old boy died in a freak MRI accident, what have medical regulators done to ensure greater MRI safety?
Femasys and Norgenix Announce Distribution Agreement for Groundbreaking New Device for Infertility Diagnosis
August 16, 2011 9:41 am | by Bio-Medicine.Org | News | CommentsSPARTANBURG, S.C., Aug. 16, 2011 /- Femasys Inc. and Norgenix Pharmaceuticals, LLC today announced an agreement for exclusive distribution rights in the United States as well as US territories and military bases for Femasys' FemVue™ Saline-Air Device. This FDA cleared device is used...
Childbearing May Increase Risk of Hormone Receptor-Negative Breast Cancer in African-American Women
August 16, 2011 9:40 am | by AACR | News | CommentsTweet • Two or more full-term births put African-American women at higher risk.• Increased risk occurred only in women who did not breast-feed. PHILADELPHIA — African-American women are at higher risk for hormone receptor-negative...
QIAGEN and Pfizer Partner to Develop Companion Diagnostic for Novel Compound in Global Clinical Trials for Lung Cancer
August 15, 2011 11:40 pm | by Bio-Medicine.Org | News | CommentsGERMANTOWN, Maryland and HILDEN, Germany, August 16, 2011 /- Diagnostic-therapeutic combination aims to improve standard of care for patients with non-small cell lung cancer (NSCLC) Molecular test for KRAS gene mutations holds potential to help determine whether there is a subset...
Prometheus and the Medco Research Institute® to Evaluate the Use of Prometheus' Thiopurine Metabolite Testing for Optimizing Treatment of Inflammatory Bowel Disease Patients
August 15, 2011 9:36 am | by Bio-Medicine.Org | News | CommentsSAN DIEGO and FRANKLIN LAKES, N.J., Aug. 15, 2011 /- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostics company that is part of Nestle Health Science, and the Medco Research Institute®, LLC, a wholly-owned subsidiary of Medco Health Solutions, Inc. (NYSE: MHS ),...
Millennium HealthCare Inc. Engages KBL, LLP
August 15, 2011 9:36 am | by Bio-Medicine.Org | News | CommentsSYOSSET, N.Y., Aug. 15, 2011 /- Millennium HealthCare Inc. (Symbol: MHCC) announced today that it has engaged KBL, LLP, a Public Company Accounting Oversight Board (PCAOB) accounting firm as the Company's accountant and advisor. KBL, LLP provides a combination of technology, intellectual...
Childhood Cancer Survivors in Poor Health at Greater Risk for Unemployment in Adulthood
August 15, 2011 9:36 am | by AACR | News | CommentsTweet • Poor health led to an eightfold higher risk for unemployment. • Those with neurocognitive deficits less likely to hold professional positions.• Neurocognitive limitations affected women’s occupation...
Quest Diagnostics Declares Quarterly Cash Dividend
August 13, 2011 9:40 pm | by Bio-Medicine.Org | News | CommentsMADISON, N.J., Aug. 12, 2011 /- Quest Diagnostics Incorporated (NYSE: DGX ), the world's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend of $0.10 per share, payable on October 24, 2011,...
Conserving Your Momentum
August 13, 2011 8:33 am | by Diagnostic Imaging | News | CommentsRemember your education in physics? No, not the stuff from your radiology residency; I'm talking about undergraduate classes, or even earlier. Chances are you thought more than a couple of times about how irrelevant this stuff was going to be, once you got into med school. I know I did.
Chairman of Global Guide to COPD Diagnosis Committee Visited West China Hospital
August 11, 2011 9:42 am | by Bio-Medicine.Org | News | CommentsCHENGDU, China, Aug. 11, 2011 /PRNewswire-Asia/ -- Recently, Professor Rodriguez-Roisin, the first and present Chairman of the Global Initiative Committee for Chronic Obstructive Pulmonary Disease, the first Chairman of the European Respiratory Society, and also the Dean of the medical...
Concord Medical and GE Healthcare Sign MOU for Preferred Partnership in China
August 11, 2011 6:41 am | by Bio-Medicine.Org | News | CommentsBEIJING, Aug. 11, 2011 /PRNewswire-Asia-FirstCall/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM ), the operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that it has signed an Memorandum...
U.S. Department of Homeland Security Validates Performance of PositiveID Corporation's Multiplex BioThreat Assay Through an In-House Blind Study
August 11, 2011 4:40 am | by PositiveID | News | CommentsU.S. Department of Homeland Security Validates Performance of PositiveID Corporation's Multiplex BioThreat Assay Through an In-House Blind Study
A Case for Prior Authorization of Imaging Services
August 10, 2011 9:37 pm | by Diagnostic Imaging | News | CommentsThe head of a speciality benefit management company gives his take on why prior authorization is the only system that ensures that vast data is seriously considered in patient diagnosis and treatment.
Enigma Diagnostics and GSK Announce Collaboration on Assay Development and Commercialization of Enigma's ML Platform
August 10, 2011 7:38 am | by Bio-Medicine.Org | News | CommentsLONDON and OXFORD, England, Aug. 10, 2011 /- Enigma Diagnostics Limited (Enigma) and GlaxoSmithKline (GSK) today announced that they have signed agreements for the supply and commercialization on an exclusive basis of the Enigma® ML system in Europe and other designated key...
CT Study Stratifies Death Risk of Coronary Artery Disease
August 10, 2011 5:39 am | by Diagnostic Imaging | News | CommentsA study assessing CT angiographs of nearly 25,000 patients presumed to be free of coronary artery disease (CAD) has shown both obstructive and nonobstructive forms of the disease to increase the risk of death.
DNA and RNA Probes: Preparation, Formats, Labeling, Amplification, Detection
August 9, 2011 4:39 am | by Bio-Medicine.Org | News | CommentsNEW YORK, Aug. 9, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: DNA and RNA Probes: Preparation, Formats, Labeling, Amplification, Detection...
Marken Announces Appointment of Christopher O'Connell as New Chief Financial Officer
August 9, 2011 4:38 am | by Bio-Medicine.Org | News | CommentsLONDON, Aug. 9, 2011 /- Marken Ltd., a leading life sciences supply chain management organization, today announced the appointment of Christopher O'Connell as their new Chief Financial Officer (CFO) effective August 1, 2011. Mr. O'Connell joins Marken with more than 20 years experience in...
PositiveID Corporation Appoints Pietro Galassetti, MD, PhD to Its Scientific Advisory Board
August 8, 2011 12:38 pm | by PositiveID | News | CommentsPositiveID Corporation Appoints Pietro Galassetti, MD, PhD to Its Scientific Advisory Board
